BACKGROUND: The ARISTOTLE trial demonstrated that apixaban had significantly lower
rates of stroke/systemic embolism (SE) and major bleeding than warfarin; however, no direct …

… (SE) among patients with non-valvular atrial fibrillation (NVAF), but the comparative risk
of major bleeding varies between DOACs and warfarin. Using US Department of Defense (DOD) …

The treatment of atrial fibrillation (AF) patients has altered … and under-education of AF patients
continue [5] despite their … In a 1-year study of elderly patients with AF, 26% of patients 80 …

… Atrial fibrillation (AF) is the most common sustained cardiac … ) overwhelms endogenous
antioxidant defenses, causing … were predictors of mortality in a population with CAD. This study …

… individuals diagnosed with atrial fibrillation in the Defense Medical Surveillance System, and
… of atrial fibrillation in our study population may not have been detected if the patient was in …

… represent the US population. Casualties from military combat are a unique group of patients,
and our results may not be generalizable to patients from the general population. Third, the …

Atrial fibrillation (AF) is associated with structural, electrical, and contractile remodeling of the
atria. Development and progression of atrial fibrosis is the hallmark of structural remodeling …

… selenium dependent GPx as a mechanism of defense against the LPS-induced oxidative
stress … only Caucasian AF patients, and we could not extend our findings to other populations. …

… in the pathophysiology of atrial fibrillation. Thus, increased … from patients with atrial fibrillation.
Therefore, it seems reasonable to assume that the reinforcement of the antioxidant defense …

Background: Atrial fibrillation (AF) has been associated with myocardial oxidative stress,
and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared …